ES537520A0 - Un procedimiento para preparar nuevos peptidos atriales. - Google Patents

Un procedimiento para preparar nuevos peptidos atriales.

Info

Publication number
ES537520A0
ES537520A0 ES537520A ES537520A ES537520A0 ES 537520 A0 ES537520 A0 ES 537520A0 ES 537520 A ES537520 A ES 537520A ES 537520 A ES537520 A ES 537520A ES 537520 A0 ES537520 A0 ES 537520A0
Authority
ES
Spain
Prior art keywords
procedure
preparing new
atrial peptides
new atrial
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES537520A
Other languages
English (en)
Other versions
ES8606390A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Washington
Washington University in St Louis WUSTL
Original Assignee
University of Washington
Washington University in St Louis WUSTL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington, Washington University in St Louis WUSTL filed Critical University of Washington
Publication of ES8606390A1 publication Critical patent/ES8606390A1/es
Publication of ES537520A0 publication Critical patent/ES537520A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES537520A 1983-11-10 1984-11-08 Un procedimiento para preparar nuevos peptidos atriales. Expired ES8606390A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55137283A 1983-11-10 1983-11-10
US06/569,684 US4496544A (en) 1983-11-10 1984-01-10 Atrial Peptides

Publications (2)

Publication Number Publication Date
ES8606390A1 ES8606390A1 (es) 1986-04-01
ES537520A0 true ES537520A0 (es) 1986-04-01

Family

ID=27069747

Family Applications (1)

Application Number Title Priority Date Filing Date
ES537520A Expired ES8606390A1 (es) 1983-11-10 1984-11-08 Un procedimiento para preparar nuevos peptidos atriales.

Country Status (12)

Country Link
US (1) US4496544A (es)
EP (1) EP0142487B1 (es)
JP (1) JPH0672156B2 (es)
AU (1) AU566235B2 (es)
DE (1) DE3480930D1 (es)
DK (1) DK533484A (es)
ES (1) ES8606390A1 (es)
FI (1) FI83661C (es)
GR (1) GR80905B (es)
IE (1) IE58819B1 (es)
IL (1) IL73466A (es)
NO (1) NO844489L (es)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0116784B1 (en) * 1982-02-22 1992-06-10 Queen's University At Kingston Atrial natriuretic factor
AU572173B2 (en) * 1983-08-29 1988-05-05 Institut De Recherches Cliniques De Montreal Natriuretic factors
JPS60136596A (ja) * 1983-12-26 1985-07-20 Suntory Ltd ペプチド及びこれを有効成分とする利尿剤
US4952561A (en) * 1984-02-07 1990-08-28 Merck & Co., Inc. Cardiac atrial peptides
JPH0794473B2 (ja) * 1984-03-02 1995-10-11 サントリー株式会社 新規なペプチド及びこれを有効成分とする利尿剤
US5212286A (en) * 1984-04-19 1993-05-18 Scios Nova Inc. Atrial natriuretic/vasodilator peptide compounds
US4618600A (en) * 1984-04-19 1986-10-21 Biotechnology Research Associates, J.V. Novel polypeptide diuretic/vasodilators
EP0180615B1 (en) * 1984-04-19 1995-04-05 Scios Nova Inc. Novel atrial natriuretic/vasodilator polypeptides
AU4292785A (en) * 1984-04-24 1985-11-15 Salk Institute For Biological Studies, The Atrial peptide analogs
JPH0672157B2 (ja) * 1984-08-29 1994-09-14 味の素株式会社 新規ペプチド
US4652549A (en) * 1985-01-22 1987-03-24 Merck & Co., Inc. Cardiac anti-hypertrophic agents
US5087564A (en) * 1985-06-20 1992-02-11 Monsanto Company Release of recombinant peptides from polypeptides using V8 endopeptidase
JP3042782B2 (ja) * 1985-11-05 2000-05-22 サイオス インコーポレイテッド 心房性ナトリウム尿排泄亢進ペプチド類似化合物
US4757048A (en) * 1985-11-05 1988-07-12 Biotechnology Research Associates J.V. Synthetic analogs of atrial natriuretic peptides
AU597919B2 (en) * 1985-11-05 1990-06-14 Scios Nova Inc. Analogs of atrial natriuretic peptides
DE3614833A1 (de) * 1986-01-16 1987-07-23 Hoechst Ag Peptide mit vasorelaxierender, natriuretischer und diuretischer wirkung, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung
US4716147A (en) * 1986-03-27 1987-12-29 Monsanto Company Synthetic airial peptides
US4721704A (en) * 1986-05-09 1988-01-26 Peninsula Laboratories, Inc. Potent synthetic atrial peptide analogs
EP0246795A3 (en) * 1986-05-20 1990-04-04 Advanced Peptide Development Limited Synthetic natriuretic peptides
US4740499A (en) * 1986-07-28 1988-04-26 Monsanto Company Method of enhancing the bioactivity of atrial peptides
DE3723551A1 (de) * 1987-07-16 1989-01-26 Hoechst Ag Peptide mit vasorelaxierender, natriuretischer und diuretischer wirkung, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung
US5565606A (en) * 1986-10-21 1996-10-15 Hoechst Aktiengesellschaft Synthesis of peptide aminoalkylamides and peptide hydrazides by the solid-phase method
US4804650A (en) * 1986-10-28 1989-02-14 Biotechnology Research Associates, J.V. Analogs of atrial natriuretic peptides
CA1319099C (en) * 1987-01-23 1993-06-15 James A. Nathanson Atriopeptins, guanylate cyclase activators, and phosphodiesterase inhibitors as treatment for glaucoma, hydrocephalus and cerebral edema (cranial fluid volume dysfunction)
US5500230A (en) * 1987-01-23 1996-03-19 The General Hospital Corporation Method for treatment of glaucoma with nitrogen containing guanylate cyclase activators
IT1216865B (it) 1987-02-03 1990-03-14 Eniricerche Spa Derivato argininico, procedimento per la sua preparazione e suo impiego nelle sintesi peptidiche.
DE3881467T2 (de) * 1987-10-09 1993-10-21 Agency Ind Science Techn Vasokonstriktor-Peptid.
US4935492A (en) * 1987-12-24 1990-06-19 California Biotechnology Inc. Cyclic analogs of atrial natriuretic peptides
US5047397A (en) * 1988-08-26 1991-09-10 California Biotechnology Inc. Linear analogs of atrial natriuretic peptides
CA1339210C (en) * 1988-05-31 1997-08-05 John Lewicki Recombinant techniques for production of novel natriuretic and vasodilator peptides
US5114923A (en) * 1988-05-31 1992-05-19 California Biotechnology Inc. Recombinant techniques for production of novel natriuretic and vasodilator peptides
JP2801079B2 (ja) * 1990-11-14 1998-09-21 サントリー株式会社 Ａｎｐ関連新規ペプチド
JP2809533B2 (ja) * 1991-01-31 1998-10-08 壽之 松尾 Ｃｎｐ類似体ペプチド
US6525022B1 (en) 1993-11-12 2003-02-25 Genentech, Inc. Receptor specific atrial natriuretic peptides
US5665704A (en) * 1993-11-12 1997-09-09 Genentech, Inc. Receptor specific atrial natriuretic peptides
US5846932A (en) * 1993-11-12 1998-12-08 Genentech, Inc. Receptor specific atrial natriuretic peptides
US5486519A (en) * 1994-08-22 1996-01-23 Greenwald; James E. Method for treatment of acute renal failure
US5521191A (en) * 1994-10-17 1996-05-28 Washington University Method for treatment of arterial stenosis
US20060177870A1 (en) * 2003-04-28 2006-08-10 Ciphergen Biosystems, Inc Immunoassays
DE602004029680D1 (de) 2003-06-20 2010-12-02 Mayo Foundation Isoformen von gehirn-natriuretischem peptid
WO2007115175A2 (en) * 2006-03-30 2007-10-11 Palatin Technologies, Inc. Cyclic natriuretic peptide constructs
US8580746B2 (en) 2006-03-30 2013-11-12 Palatin Technologies, Inc. Amide linkage cyclic natriuretic peptide constructs
WO2007115182A2 (en) * 2006-03-30 2007-10-11 Palatin Technologies, Inc. Linear natriuretic peptide constructs
WO2008021872A1 (en) * 2006-08-08 2008-02-21 Mayo Foundation For Medical Education And Research Diuretic and natriuretic polypeptides
WO2009036448A2 (en) * 2007-09-15 2009-03-19 Mayo Foundation For Medical Education And Research Natriuretic peptide receptor-c agonists
WO2013032784A1 (en) 2011-08-30 2013-03-07 Mayo Foundation For Medical Education And Research Natriuretic polypeptides
US9611305B2 (en) 2012-01-06 2017-04-04 Mayo Foundation For Medical Education And Research Treating cardiovascular or renal diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA846084B (en) * 1983-08-29 1985-05-29 Montreal Inst Rech Cliniques Natriuretic factors

Also Published As

Publication number Publication date
US4496544A (en) 1985-01-29
NO844489L (no) 1985-05-13
AU3525284A (en) 1985-05-16
EP0142487B1 (en) 1990-01-03
DE3480930D1 (de) 1990-02-08
FI83661B (fi) 1991-04-30
IL73466A (en) 1989-03-31
IL73466A0 (en) 1985-02-28
DK533484D0 (da) 1984-11-09
FI844424A0 (fi) 1984-11-09
IE842881L (en) 1985-05-10
DK533484A (da) 1985-05-11
FI83661C (fi) 1991-08-12
GR80905B (en) 1985-04-02
JPH0672156B2 (ja) 1994-09-14
AU566235B2 (en) 1987-10-15
JPS60214797A (ja) 1985-10-28
EP0142487A2 (en) 1985-05-22
EP0142487A3 (en) 1986-04-30
FI844424L (fi) 1985-05-11
ES8606390A1 (es) 1986-04-01
IE58819B1 (en) 1993-11-17

Similar Documents

Publication Publication Date Title
ES537520A0 (es) Un procedimiento para preparar nuevos peptidos atriales.
ES542310A0 (es) Procedimiento para preparar un polipeptido
ES551113A0 (es) Procedimiento para preparar peptidos trifluormetilcetona-sustituidos.
ES516866A0 (es) Un procedimiento para preparar nuevos compuestos peptidicos.
ES540110A0 (es) Un procedimiento para preparar nuevos peptidos hipotensivos.
AR221717A1 (es) Un procedimiento para preparar la 17 alfa-butiriloxi-1 beta-hidroxi-21-propioniloxi-4-pregnen-3,20-diona
ES534694A0 (es) Un procedimiento para preparar cefuroxima sodica
ES529728A0 (es) Procedimiento para preparar amino-2-fenil-5-benzodiazepinas-1, 3
MX161186A (es) Procedimiento para preparar peptidos
ES544751A0 (es) Un procedimiento para la preparacion de -1-metilcarbapenems.
ES519652A0 (es) Un procedimiento para obtener s-adenosil-metionina.
AR231308A1 (es) Un procedimiento para preparar 1-be-d-ribofuranosil-1,2,4-triazolcarboxamida rivavirina
ES524245A0 (es) Procedimiento para obtener un polipeptido
ES535455A0 (es) Un procedimiento para preparar peptidos
ES535120A0 (es) Un procedimiento para la produccion de peptidos.
ES517459A0 (es) Un procedimiento para preparar un dentifrico estable.
ES531550A0 (es) Procedimiento para preparar un fenilaminobencoalcanol
ES536050A0 (es) Un procedimiento para preparar fenil-carbamatos sustituidos
ES518758A0 (es) Un procedimiento para preparar azetidinas.
ES534170A0 (es) Un procedimiento para preparar 1-piridil-alquil-4-aril-piperazinas
ES531910A0 (es) Un procedimiento para preparar nuevas 5-acil-2-(1h)-piridinonas.
ES535727A0 (es) Un procedimiento para la preparacion de nuevos peptidos.
ES538072A0 (es) Un procedimiento para preparar un difenil-eter
ES538192A0 (es) Un procedimiento para preparar un 2-bromo-6b-9a - difluoro-11b, 17a, 21-trihidroxi-1, 4-pregnadien-3, 20-diona-17, 21-diester
ES546530A0 (es) Un procedimiento para preparar un polipeptido hibrido.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20001102